デフォルト表紙
市場調査レポート
商品コード
1446496

空間OMICSの市場規模、シェア、動向分析レポート:技術別、製品タイプ別、ワークフロー別、サンプルタイプ別、最終用途別、地域別、セグメント予測、2024年~2030年

Spatial OMICS Market Size, Share, & Trends Analysis Report By Technology (Spatial Transcriptomics, Spatial Genomics, Spatial Proteomics), By Product, By Workflow, By Sample Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
空間OMICSの市場規模、シェア、動向分析レポート:技術別、製品タイプ別、ワークフロー別、サンプルタイプ別、最終用途別、地域別、セグメント予測、2024年~2030年
出版日: 2024年02月08日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

空間OMICS市場の成長と動向:

Grand View Research, Incの最新レポートによると、世界の空間OMICS市場規模は2030年までに7億1,480万米ドルに達する見込みです。

2024年から2030年までのCAGRは10.21%で拡大する見込み。COVID-19パンデミックは世界の多くの産業を減速させました。しかし、この市場はパンデミックによる広範な悪影響には直面しませんでした。

新興企業や老舗企業は製品開発を続け、斬新なソリューションを発表し、イノベーターを超えて提供する製品を民主化し、M&Aに取り組みました。空間OMICS分野はハイパープレックスイメージングに端を発しているが、主なプレーヤーは空間トランスクリプトミクスソリューションと製品の開発へとシフトしています。

組織、遺伝子、単一細胞のシーケンスにおける急速な進歩は、空間ゲノムシーケンスの出現をもたらしました。空間OMICS技術は、定量的遺伝子発現データと組織切片内のDNAおよびRNAマッピングの可視化を提供します。空間OMICSの新規技術の開発は、診断だけでなくトランスレーショナルリサーチの分野にも有利な機会を生み出すと予想されています。

空間ゲノミクス技術分野は、新規プラットフォームの立ち上げの増加により、予測期間を通じて最も速いCAGRで拡大すると予想されます。トランスクリプトミクス、ゲノミクス、プロテオミクス研究におけるハイスループットソリューションの統合により、疾患発生とゲノム位置の関連性が明らかになった。

空間OMICS研究のための新しい自動化ソリューションの発売により、機器製品は2020年に第2位のシェアを占めました。例えば、2021年3月、Rebus Biosystems社は、組織生物学の理解を深めるための新しいRebus Esper空間オミックスプラットフォームを発表しました。この新しい統合型自動装置は、高度な流体工学、イメージング、化学、バイオインフォマティクスのソリューションを使用することにより、サブセル分解能と空間的コンテキストを持つ定量的な単一細胞、単一分子データを提供します。

新鮮凍結サンプルタイプは、予測期間中に大きな成長が見込まれます。プロテオミクスにおける新鮮凍結サンプルの利点は、いくつかの調査によって検証されています。例えば、2021年3月、ある研究は、Filter Aided Sample Preparation(FASP)技術は、ホルマリン固定パラフィン包埋(FFPE)サンプルよりも新鮮凍結サンプルを使用することで、20%多くのタンパク質同定をもたらすと結論づけた。

北米は、トランスレーショナルリサーチへの注目の高まり、ゲノミクスとシーケンス技術への政府支援の増加、個別化医療への高い需要、トランスレーショナルリサーチと学術研究機関のかなりの数の存在により、2020年に最大のシェアを占めました。

空間OMICS市場レポートハイライト

  • 技術別では、空間トランスクリプトミクスが2023年に最大のシェアを占め、利用可能な製品のほとんどが位置情報を得るためのmRNA解析に基づいていることから、予測期間を通じて優位性を維持すると予測されます。
  • 製品別では、機器を稼働させるために試薬やプローブを頻繁に購入するため、消耗品セグメントが2023年に最大の収益シェアを占めました。
  • ワークフロー別では、技術的進歩や新製品の市場投入により、機器分析分野が2023年の市場を独占しました。
  • 新鮮凍結サンプルタイプは、2024年から2030年にかけて有利なCAGRで拡大すると予測されます。新鮮凍結組織はタンパク質のネイティブな状態を保持するため、空間プロテオミクス分析に採用されるからです。
  • 最終用途別では、大学における生物医学研究の増加により、学術・トランスレーショナル研究機関が2023年の市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 空間オミクス市場の変数と動向

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 空間OMICS市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 テクノロジービジネス分析

  • 世界の空間OMICS市場:技術変動分析
  • 空間トランスクリプトミクス
    • 2018年から2030年の市場推計・予測
  • 空間ゲノミクス
    • 2018年から2030年の市場推計・予測
  • 空間プロテオミクス
    • 2018年から2030年の市場推計・予測

第5章 製品ビジネス分析

  • 世界の空間OMICS市場:製品変動分析
  • 機器
  • 消耗品
  • ソフトウェア

第6章 ワークフロービジネス分析

  • 世界の空間OMICS市場:ワークフロー変動分析
  • サンプル調製
    • 2018年から2030年の市場推計・予測
  • 機器分析
    • 2018年から2030年の市場推計・予測
  • データ分析
    • 2018年から2030年の市場推計・予測

第7章 サンプルタイプのビジネス分析

  • 世界の空間OMICS市場:サンプルタイプの変動分析
  • FFPE
  • 新鮮な冷凍

第8章 最終用途ビジネス分析

  • 世界の空間OMICS市場:最終用途の変動分析
  • 学術およびトランスレーショナル調査機関
    • 2018年から2030年の市場推計・予測
  • 製薬会社およびバイオテクノロジー会社
    • 2018年から2030年の市場推計・予測

第9章 地域ビジネス分析

  • 地域市場シェア分析、2023年および2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • UAE
    • クウェート

第10章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • Company position analysis, 2023
  • 企業プロファイル・一覧表
    • 10x Genomics
    • Dovetail Genomics(Cantata Bio.)
    • S2 Genomics, Inc.
    • NanoString Technologies, Inc.
    • Seven Bridges Genomics
    • PerkinElmer, Inc.
    • Bio-Techne
    • Danaher Corporation
    • IonPath, Inc.
    • Millennium Science Pty Ltd.
    • Akoya Biosciences, Inc.
    • Standard BioTools
    • Diagenode Diagnostics(Hologic, Inc.)
    • Biognosys
    • Rebus Biosystems, Inc.
    • Ultivue, Inc.
    • BioSpyder, Inc.
    • Bruker
    • RareCyte, Inc
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America spatial OMICS market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 North America spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 7 North America spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 9 U.S. spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 11 U.S. spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 12 U.S. spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Canada spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 15 Canada spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 16 Canada spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 17 Canada spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Europe spatial OMICS market, by region, 2018 - 2030 (USD Million)
  • Table 19 Europe spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Europe spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Europe spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 23 Europe spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 25 UK spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 26 UK spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 UK spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 28 UK spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Germany spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Germany spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 31 Germany spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 32 Germany spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 33 Germany spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Italy spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Italy spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 36 Italy spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 37 Italy spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 38 Italy spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 France spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 40 France spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 41 France spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 42 France spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 43 France spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Spain spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Spain spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 46 Spain spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 47 Spain spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 48 Spain spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Sweden spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Sweden spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 51 Sweden spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 52 Sweden spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 53 Sweden spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Denmark spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Denmark spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 56 Denmark spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 57 Denmark spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 58 Denmark spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Norway spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 60 Norway spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 61 Norway spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 62 Norway spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 63 Norway spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific spatial OMICS market, by region, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 China spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 71 China spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 72 China spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 73 China spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 74 China spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Japan spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 76 Japan spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 77 Japan spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 78 Japan spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 79 Japan spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 India spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 81 India spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 82 India spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 83 India spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 84 India spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 South Korea spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 86 South Korea spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 87 South Korea spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 88 South Korea spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 89 South Korea spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Australia spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 91 Australia spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 92 Australia spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 93 Australia spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 94 Australia spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Thailand spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 96 Thailand spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 97 Thailand spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 98 Thailand spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 99 Thailand spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Latin America spatial OMICS market, by region, 2018 - 2030 (USD Million)
  • Table 101 Latin America spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 102 Latin America spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 103 Latin America spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 104 Latin America spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 105 Latin America spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 106 Brazil spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 107 Brazil spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 108 Brazil spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 109 Brazil spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 110 Brazil spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 Mexico spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 112 Mexico spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 113 Mexico spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 114 Mexico spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 115 Mexico spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 Argentina spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 117 Argentina spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 118 Argentina spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 119 Argentina spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 120 Argentina spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 121 Middle East & Africa spatial OMICS market, by region, 2018 - 2030 (USD Million)
  • Table 122 Middle East & Africa spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 123 Middle East & Africa spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 124 Middle East & Africa spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 125 Middle East & Africa spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 126 Middle East & Africa spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 127 South Africa spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 128 South Africa spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 129 South Africa spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 130 South Africa spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 131 South Africa spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 137 UAE spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 138 UAE spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 139 UAE spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 140 UAE spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 141 UAE spatial OMICS market, by end-use, 2018 - 2030 (USD Million)
  • Table 142 Kuwait spatial OMICS market, by technology, 2018 - 2030 (USD Million)
  • Table 143 Kuwait spatial OMICS market, by product, 2018 - 2030 (USD Million)
  • Table 144 Kuwait spatial OMICS market, by workflow, 2018 - 2030 (USD Million)
  • Table 145 Kuwait spatial OMICS market, by sample type, 2018 - 2030 (USD Million)
  • Table 146 Kuwait spatial OMICS market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Spatial OMICS market: market outlook
  • Fig. 9 Spatial OMICS competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Spatial OMICS market driver impact
  • Fig. 13 Spatial OMICS market restraint impact
  • Fig. 14 Spatial OMICS market: Technology movement analysis
  • Fig. 15 Spatial OMICS market: Technology outlook and key takeaways
  • Fig. 16 Spatial transcriptomics market estimates and forecasts, 2018 - 2030
  • Fig. 17 Spatial genomics estimates and forecasts, 2018 - 2030
  • Fig. 18 Spatial proteomics estimates and forecasts, 2018 - 2030
  • Fig. 19 Spatial OMICS Market: Product movement Analysis
  • Fig. 20 Spatial OMICS market: Product outlook and key takeaways
  • Fig. 21 Instruments market estimates and forecasts, 2018 - 2030
  • Fig. 22 Automated market estimates and forecasts, 2018 - 2030
  • Fig. 23 Semi-automated market estimates and forecasts, 2018 - 2030
  • Fig. 24 Manual market estimates and forecasts, 2018 - 2030
  • Fig. 25 Sequencing platforms market estimates and forecasts, 2018 - 2030
  • Fig. 26 IHC market estimates and forecasts, 2018 - 2030
  • Fig. 27 Microscopy market estimates and forecasts, 2018 - 2030
  • Fig. 28 Flow cytometry market estimates and forecasts, 2018 - 2030
  • Fig. 29 Mass spectrometry market estimates and forecasts, 2018 - 2030
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030
  • Fig. 31 Consumables market estimates and forecasts, 2018 - 2030
  • Fig. 32 Software market estimates and forecasts, 2018 - 2030
  • Fig. 33 Bioinformatics tools market estimates and forecasts, 2018 - 2030
  • Fig. 34 Imaging tools market estimates and forecasts, 2018 - 2030
  • Fig. 35 Storage and management databases market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spatial OMICS Market: Workflow movement Analysis
  • Fig. 37 Spatial OMICS market: Workflow outlook and key takeaways
  • Fig. 38 Sample preparation market estimates and forecasts, 2018 - 2030
  • Fig. 39 Instrumental analysis market estimates and forecasts, 2018 - 2030
  • Fig. 40 Data analysis market estimates and forecasts, 2018 - 2030
  • Fig. 41 Spatial OMICS market: Sample type movement Analysis
  • Fig. 42 Spatial OMICS market: Sample type outlook and key takeaways
  • Fig. 43 FFPE market estimates and forecasts, 2018 - 2030
  • Fig. 44 Fresh frozen market estimates and forecasts, 2018 - 2030
  • Fig. 45 Spatial OMICS Market: End-use movement Analysis
  • Fig. 46 Spatial OMICS market: End-use outlook and key takeaways
  • Fig. 47 Academic & translational research institutes market estimates and forecasts, 2018 - 2030
  • Fig. 48 Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 - 2030
  • Fig. 49 Global spatial OMICS market: Regional movement analysis
  • Fig. 50 Global spatial OMICS market: Regional outlook and key takeaways
  • Fig. 51 North America market estimates and forecasts, 2018 - 2030
  • Fig. 52 U.S. key country dynamics
  • Fig. 53 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 54 Canada key country dynamics
  • Fig. 55 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 56 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 57 UK key country dynamics
  • Fig. 58 UK market estimates and forecasts, 2018 - 2030
  • Fig. 59 Germany key country dynamics
  • Fig. 60 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 61 France key country dynamics
  • Fig. 62 France market estimates and forecasts, 2018 - 2030
  • Fig. 63 Italy key country dynamics
  • Fig. 64 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 65 Spain key country dynamics
  • Fig. 66 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 67 Denmark key country dynamics
  • Fig. 68 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 69 Sweden key country dynamics
  • Fig. 70 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 71 Norway key country dynamics
  • Fig. 72 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 74 China key country dynamics
  • Fig. 75 China market estimates and forecasts, 2018 - 2030
  • Fig. 76 Japan key country dynamics
  • Fig. 77 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 78 India key country dynamics
  • Fig. 79 India market estimates and forecasts, 2018 - 2030
  • Fig. 80 Thailand key country dynamics
  • Fig. 81 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 82 South Korea key country dynamics
  • Fig. 83 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 84 Australia key country dynamics
  • Fig. 85 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 86 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 87 Brazil key country dynamics
  • Fig. 88 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 89 Mexico key country dynamics
  • Fig. 90 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 91 Argentina key country dynamics
  • Fig. 92 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 93 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 94 South Africa key country dynamics
  • Fig. 95 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 96 Saudi Arabia key country dynamics
  • Fig. 97 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 98 UAE key country dynamics
  • Fig. 99 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 100 Kuwait key country dynamics
  • Fig. 101 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 102 Market position of key market players- Spatial OMICS market
目次
Product Code: GVR-4-68039-463-5

Spatial OMICS Market Growth & Trends:

The global spatial OMICS market size is expected to reach USD 714.8 million by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.21% from 2024 to 2030. The COVID-19 pandemic slowed down many industries worldwide. However, this market did not face the extensive negative impact of the pandemic.

Startups and well-established players continued their product development and launched novel solutions, democratized their offerings beyond innovators, and engaged in mergers & acquisitions. The spatial OMICS field originated from hyperplexed imaging; however, key players have shifted toward the development of spatial transcriptomics solutions and products.

Rapid advances in the sequencing of tissues, genes, and single cells have resulted in the emergence of spatial genomic sequencing. Spatial OMICS techniques offer quantitative gene expression data and visualization of DNA and RNA mapping within tissue sections. The development of novel technologies for spatial OMICS is anticipated to create lucrative opportunities for the fields of translational research as well as diagnostics.

The spatial genomics technology segment is expected to expand at the fastest CAGR throughout the forecast period owing to a rise in the launch of novel platforms. The integration of high-throughput solutions in transcriptomics, genomics, and proteomics studies has enabled determining the link between disease occurrence and genome position.

The instruments product held the second-largest share in 2020 owing to the launch of new automated solutions for spatial OMIC studies. For instance, in March 2021, Rebus Biosystems launched the new Rebus Esper spatial omics platform for a better understanding of tissue biology. The new integrated and automated instrument delivers quantitative single-cell, single-molecule data with subcellular resolution and spatial context by using advanced fluidics, imaging, chemistry, and bioinformatics solutions.

The fresh frozen sample type is expected to witness significant growth over the forecast period. The advantages of fresh frozen samples in proteomics are validated by several research studies. For instance, in March 2021, a study concluded that Filter Aided Sample Preparation (FASP) technique yielded 20% more protein identifications by using fresh frozen samples than formalin-fixed, paraffin-embedded (FFPE) samples.

North America held the largest share in 2020 owing to an increase in focus on translational research, rise in government support for genomics and sequencing technologies, high demand for personalized medicine, and the presence of a substantial number of translational and academic research organizations.

Spatial OMICS Market Report Highlights:

  • By technology, spatial transcriptomics accounted for the largest share in 2023 and is projected to maintain its dominance throughout the forecast period as most of the available products are based on mRNA analysis for positional information
  • In terms of product, the consumables segment held the largest revenue share in 2023 owing to the frequent purchase of reagents and probes to run instruments
  • Based on workflow, the instrumental analysis segment dominated the market in 2023 owing to the technological advancements and launch of novel products in the market
  • The fresh frozen sample type is anticipated to expand at a lucrative CAGR from 2024 to 2030 as fresh frozen tissue preserves the native state of proteins and hence are adopted in spatial proteomics analysis
  • On the basis of end use, the academic and translational research institutes dominated the market in 2023 owing to an increase in biomedical research in academic universities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Product
    • 1.2.3. Workflow
    • 1.2.4. Sample Type
    • 1.2.5. End-use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Spatial OMICS Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Emerging potential of spatial OMICS analysis as a cancer diagnostic tool
      • 3.2.1.2. Advent of fourth generation of sequencing (in situ sequencing)
      • 3.2.1.3. Increasing market competition due to emerging players
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Slow implementation of technology
      • 3.2.2.2. Well-established workflows for conventional OMICS analysis
  • 3.3. Spatial OMICS Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Global Spatial OMICS Market: Technology Movement Analysis
  • 4.2. Spatial Transcriptomics
    • 4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3. Spatial Genomics
    • 4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4. Spatial Proteomics
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Global Spatial OMICS Market: Product Movement Analysis
  • 5.2. Instruments
    • 5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.2.2. By Mode
      • 5.2.2.1. Automated
      • 5.2.2.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.2.2. Semi-automated
      • 5.2.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.2.3. Manual
      • 5.2.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.2.3. By Type
      • 5.2.3.1. Sequencing Platforms
      • 5.2.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.3.2. IHC
      • 5.2.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.3.3. Microscopy
      • 5.2.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.3.4. Flow Cytometry
      • 5.2.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.3.5. Mass Spectrometry
      • 5.2.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.3.6. Others
      • 5.2.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3. Consumables
    • 5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Software
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Bioinformatics tools
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Imaging tools
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Storage and management databases
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Workflow Business Analysis

  • 6.1. Global Spatial OMICS Market: Workflow Movement Analysis
  • 6.2. Sample Preparation
    • 6.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.3. Instrumental Analysis
    • 6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Data Analysis
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Sample Type Business Analysis

  • 7.1. Global Spatial OMICS Market: Sample Type Movement Analysis
  • 7.2. FFPE
    • 7.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 7.3. Fresh Frozen
    • 7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. End-use Business Analysis

  • 8.1. Global spatial OMICS Market: End-use Movement Analysis
  • 8.2. Academic & Translational Research Institutes
    • 8.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 8.3. Pharmaceutical and Biotechnology Companies
    • 8.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Regional Market Share Analysis, 2023 & 2030
  • 9.2. North America
    • 9.2.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key country dynamics
      • 9.2.2.2. Regulatory framework
      • 9.2.2.3. Competitive scenario
      • 9.2.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key country dynamics
      • 9.2.3.2. Regulatory framework
      • 9.2.3.3. Competitive scenario
      • 9.2.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Regulatory framework
      • 9.3.4.3. Competitive scenario
      • 9.3.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key country dynamics
      • 9.3.5.2. Regulatory framework
      • 9.3.5.3. Competitive scenario
      • 9.3.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key country dynamics
      • 9.3.6.2. Regulatory framework
      • 9.3.6.3. Competitive scenario
      • 9.3.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.7. Norway
      • 9.3.7.1. Key country dynamics
      • 9.3.7.2. Regulatory framework
      • 9.3.7.3. Competitive scenario
      • 9.3.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key country dynamics
      • 9.3.8.2. Regulatory framework
      • 9.3.8.3. Competitive scenario
      • 9.3.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.9. Denmark
      • 9.3.9.1. Key country dynamics
      • 9.3.9.2. Regulatory framework
      • 9.3.9.3. Competitive scenario
      • 9.3.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company position analysis, 2023
  • 10.4. Company Profiles/Listing
    • 10.4.1. 10x Genomics
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Dovetail Genomics (Cantata Bio.)
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. S2 Genomics, Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. NanoString Technologies, Inc.
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Seven Bridges Genomics
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. PerkinElmer, Inc.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Bio-Techne
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Danaher Corporation
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. IonPath, Inc.
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Millennium Science Pty Ltd.
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives
    • 10.4.11. Akoya Biosciences, Inc.
      • 10.4.11.1. Company overview
      • 10.4.11.2. Financial performance
      • 10.4.11.3. Product benchmarking
      • 10.4.11.4. Strategic initiatives
    • 10.4.12. Standard BioTools
      • 10.4.12.1. Company overview
      • 10.4.12.2. Financial performance
      • 10.4.12.3. Product benchmarking
      • 10.4.12.4. Strategic initiatives
    • 10.4.13. Diagenode Diagnostics (Hologic, Inc.)
      • 10.4.13.1. Company overview
      • 10.4.13.2. Financial performance
      • 10.4.13.3. Product benchmarking
      • 10.4.13.4. Strategic initiatives
    • 10.4.14. Biognosys
      • 10.4.14.1. Company overview
      • 10.4.14.2. Financial performance
      • 10.4.14.3. Product benchmarking
      • 10.4.14.4. Strategic initiatives
    • 10.4.15. Rebus Biosystems, Inc.
      • 10.4.15.1. Company overview
      • 10.4.15.2. Financial performance
      • 10.4.15.3. Product benchmarking
      • 10.4.15.4. Strategic initiatives
    • 10.4.16. Ultivue, Inc.
      • 10.4.16.1. Company overview
      • 10.4.16.2. Financial performance
      • 10.4.16.3. Product benchmarking
      • 10.4.16.4. Strategic initiatives
    • 10.4.17. BioSpyder, Inc.
      • 10.4.17.1. Company overview
      • 10.4.17.2. Financial performance
      • 10.4.17.3. Product benchmarking
      • 10.4.17.4. Strategic initiatives
    • 10.4.18. Bruker
      • 10.4.18.1. Company overview
      • 10.4.18.2. Financial performance
      • 10.4.18.3. Product benchmarking
      • 10.4.18.4. Strategic initiatives
    • 10.4.19. RareCyte, Inc
      • 10.4.19.1. Company overview
      • 10.4.19.2. Financial performance
      • 10.4.19.3. Product benchmarking
      • 10.4.19.4. Strategic initiatives